Systems for the collection of clinical data
HelpDesk: phone: +420 549 498 281
e-mail:
 

Projects of the Institute of Biostatistics and Analyses at Masaryk University

The registries listed below can be sorted by various criteria. One possibility is the classification according to medical branches (click on the branch of your interest in the right column). Some registries form part of another, broader project::

  • NOP On-line registries: The NOP On-line project is an information portal of the Czech National Cancer Control Programme [www.onconet.cz]. This project involves, among others, a number of registries, which are aimed at a complex communication of data results of oncology and epidemiology research in the Czech Republic.
  • CEBO registries: CEBO (Center for Evidence Based Oncology, http://cebo.registry.cz) is an independent academic institution which aims to increase the quality and quantity of oncological clinical trials initiated by doctors and medical societies from the Czech Republic and Slovakia.
  • Cardiology registries serve as an iformation support for colection of structured clinical data in cardiology. Based on their design, they enable performing elementary assessment, comparison and complex statistical analyses upon collected data.

Multicentric system for the assessment of the progress and results of biological therapy on ankylosing spondylitis.

ATTRA - Ankylosing Spondylitis

Multicentric system for the assessment of the progress and results of biological therapy on ankylosing spondylitis.

 
Multicentric system for the assessment of the progress and results of biological therapy on psoriatic arthritis.

ATTRA - Psoriatic Arthritis

Multicentric system for the assessment of the progress and results of biological therapy on psoriatic arthritis.

 
Multicentric system for the assessment of the progress and results of biological therapy on rheumatoid arthritis and juvenile idiopathic arthritis.

ATTRA - Rheumatoid Arthritis and Juvenile Idiopathic Arthritis

Multicentric system for the assessment of the progress and results of biological therapy on rheumatoid arthritis and juvenile idiopathic arthritis.